NRP1 and breast cancer: To the best of our knowledge, we are the first to show the dependence of upregulated plasma NRP-1 levels in breast cancer patients with advanced lymph node metastasis when more than 10 axillary lymph nodes or other nodes (infraclavicular, supraclavicular or internal mammary nodes) are involved (N3 disease).